Grufity logo
Grufity logo
ZIVO

ZIVO - Zivo Bioscience, Inc. Stock Price, Fair Value and News

$4.34-0.49 (-10.14%)
Market Closed as of 15 Jul 2026, 04:00 pm ET

8/100

ZIVO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

8/100

ZIVO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

ZIVO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ZIVO Price Action

Last 7 days

-8%

Last 30 days

42.9%

Last 90 days

101.3%

Trailing 12 Months

-64.2%

ZIVO RSI Chart

ZIVO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ZIVO Valuation

Market Cap

16.9M

Price/Earnings (Trailing)

-1.99

Price/Sales (Trailing)

70.11

Price/Free Cashflow

-5.48

ZIVO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

ZIVO Fundamentals

ZIVO Revenue

Revenue (TTM)

240.5K

ZIVO Earnings

Earnings (TTM)

-8.5M

Earnings Growth (Yr)

54.46%

Earnings Growth (Qtr)

37.02%

ZIVO Profitability

Return on Equity

-556.73%

Return on Assets

-1.5K%

Free Cashflow Yield

-18.26%

ZIVO Investor Care

Shares Dilution (1Y)

9.80%

Diluted EPS (TTM)

-2.15

Revenue & Growth

How Zivo Bioscience, Inc. generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
2025-174.9K240.5K-
202463.4K59.3K79.0K157.2K
2023-4.0K15.8K27.6K
202087.6K59.7K24.1K20.0K
201188.0K93.3K98.6K103.9K
2010---82.7K
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Zivo Bioscience, Inc.

ZIVO
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.
 CEO
 WEBSITEzivobioscience.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES8

Zivo Bioscience, Inc. Frequently Asked Questions

ZIVO is the stock ticker symbol of Zivo Bioscience, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Jul 10 2026, market cap of Zivo Bioscience, Inc. is 16.86 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Jul 10 2026, ZIVO's PE ratio (Price to Earnings) is -1.99 and Price to Sales (PS) ratio is 70.11. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ZIVO PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Zivo Bioscience, Inc. has provided 0.551 (multiply by 100 for percentage) rate of return.